Generation and characterization of regulatory dendritic cells derived from murine induced pluripotent stem cells

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Zhang, Qi ^a,b   Fujino, Masayuki ^b,c   Iwasaki, Shizue ^b   Hirano, Hiroshi ^b,d   Cai, Songjie ^b   Kitajima, Yuya ^b   Xu, Jinhua ^a   Li, Xiao Kang ^a,b  

^a FUDAN UNIVERSITY   (China)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d Hasumi International Research Foundation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CD86 PROTEIN, MOUSE; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IL10 PROTEIN, MOUSE; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ANTIGEN PRESENTATION; BIOSYNTHESIS; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CYTOLOGY; DENDRITIC CELL; FEMALE; IMMUNOLOGY; INDUCED PLURIPOTENT STEM CELL; LYMPHOCYTE ACTIVATION; MOUSE; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD11B; ANTIGENS, CD11C; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; DENDRITIC CELLS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INDUCED PLURIPOTENT STEM CELLS; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84893848924     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03979     Document Type: Article

References (42)

1. Banchereau, J. et al. Immunobiology of dendritic cells. Annu Rev Immunol 18, 767-811 (2000) (Pubitemid 30365397)
2. Steinman, R. M., Hawiger, D. & Nussenzweig, M. C. Tolerogenic dendritic cells. Annu Rev Immunol 21, 685-711 (2003) (Pubitemid 37174545)
3. Schmidt, S. V.,Nino-Castro, A. C.&Schultze, J. L. Regulatory dendritic cells: there is more than just immune activation. Front Immunol 3, 274 (2012)
4. Wu, J. & Horuzsko, A. Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells. Hum Immunol 70, 353-356 (2009)
5. Ezzelarab, M. & Thomson, A. W. Tolerogenic dendritic cells and their role in transplantation. Semin Immunol 23, 252-263 (2011)
6. Lo, J. & Clare-Salzler, M. J. Dendritic cell subsets and type I diabetes: focus upon DC-based therapy. Autoimmun Rev 5, 419-423 (2006) (Pubitemid 44143036)
7. Jahnisch, H. et al. Dendritic cell-based immunotherapy for prostate cancer. Clin Dev Immunol 2010, 517493 (2010)
8. Kalantari, T. et al. Generation of large numbers of highly purified dendritic cells from bone marrow progenitor cells after co-culture with syngeneic murine splenocytes. Exp Mol Pathol 94, 336-342 (2013)
9. Sato, K., Yamashita, N., Baba, M. & Matsuyama, T. Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood 101, 3581-3589 (2003) (Pubitemid 36857945)
10. Farias, A. S. et al. Vitamin D3 Induces IDO(1) Tolerogenic DCs and Enhances Treg, Reducing the Severity of EAE. CNS Neurosci Ther 19, 269-277 (2013)
11. Fu, H. et al. Dendritic cells transduced with SOCS1 gene exhibit regulatory DC properties and prolong allograft survival. Cell Mol Immunol 6, 87-95 (2009)
12. Steinbrink, K.,Wolfl, M., Jonuleit, H., Knop, J.&Enk, A.H. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159, 4772-4780 (1997) (Pubitemid 127471012)
13. Oyama, T. et al. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J Immunol 160, 1224-1232 (1998) (Pubitemid 28093419)
14. Li, G. et al. TGF-beta combined with M-CSF and IL-4 induces generation of immune inhibitory cord blood dendritic cells capable of enhancing cytokineinduced ex vivo expansion of myeloid progenitors. Blood 110, 2872-2879 (2007) (Pubitemid 350006940)
15. Hackstein, H. & Thomson, A. W. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 4, 24-34 (2004) (Pubitemid 38084129)
16. Hackstein,H. et al. Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood 101, 4457-4463 (2003) (Pubitemid 36857814)
17. Hu, J. & Wan, Y. Tolerogenic dendritic cells and their potential applications. Immunology 132, 307-314 (2011)
18. Taher, Y. A., van Esch, B. C., Hofman, G. A., Henricks, P. A. & van Oosterhout, A. J. 1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGFbeta. J Immunol 180, 5211-5221 (2008)
19. Crooke, S. T. Progress in antisense technology. Annu Rev Med 55, 61-95 (2004) (Pubitemid 38316716)
20. Fjose, A., Ellingsen, S., Wargelius, A. & Seo, H. C. RNA interference: mechanisms and applications. Biotechnol Annu Rev 7, 31-57 (2001) (Pubitemid 41081524)
21. Elbashir, S. M. et al.Duplexes of 21-nucleotide RNAs mediateRNAinterference in cultured mammalian cells. Nature 411, 494-498 (2001) (Pubitemid 32494397)
22. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006) (Pubitemid 44233629)
23. Yoshida, Y. & Yamanaka, S. iPS cells: a source of cardiac regeneration. J Mol Cell Cardiol 50, 327-332 (2011)
24. Haque, R. et al. Programming of regulatory T cells from pluripotent stem cells and prevention of autoimmunity. J Immunol 189, 1228-1236 (2012)
25. Senju, S. et al. Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Stem Cells 27, 1021-1031 (2009)
26. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007) (Pubitemid 350138099)
27. Liu, K. &Nussenzweig, M. C. Origin and development of dendritic cells. Immunol Rev 234, 45-54 (2010)
28. Kodama, H., Nose, M., Niida, S. & Nishikawa, S. Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells. Exp Hematol 22, 979-984 (1994) (Pubitemid 24292889)
29. Nakano, T., Kodama, H. & Honjo, T. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 265, 1098-1101 (1994) (Pubitemid 24293078)
30. Nakayama, N., Fang, I. & Elliott, G. Natural killer and B-lymphoid potential in CD341 cells derived from embryonic stem cells differentiated in the presence of vascular endothelial growth factor. Blood 91, 2283-2295 (1998) (Pubitemid 28155501)
31. Yamane, T. et al.Development of osteoclasts from embryonic stem cells through a pathway that is c-fms but not c-kit dependent. Blood 90, 3516-3523 (1997) (Pubitemid 27473421)
32. Senju, S. et al. Generation and genetic modification of dendritic cells derived from mouse embryonic stem cells. Blood 101, 3501-3508 (2003) (Pubitemid 36857934)
33. Platzbecker, U., Ehninger, G. & Bornhauser, M. Allogeneic transplantation of CD341 selected hematopoietic cells-clinical problems and current challenges. Leuk Lymphoma 45, 447-453 (2004) (Pubitemid 38196026)
34. Inaba, K. et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colonystimulating factor. J Exp Med 176, 1693-1702 (1992)
35. Sato, K., Yamashita, N., Baba, M. & Matsuyama, T. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 18, 367-379 (2003) (Pubitemid 36351516)
36. Fiorentino, D. F. et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146, 3444-3451 (1991)
37. Willems, F. et al. Interleukin-10 inhibits B7 and intercellular adhesionmolecule-1 expression on human monocytes. Eur J Immunol 24, 1007-1009 (1994) (Pubitemid 24093803)
38. de Waal Malefyt, R. et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174, 915-924 (1991)
39. Yagi, H. et al. Crucial role of FOXP3 in the development and function of human CD251CD41 regulatory T cells. Int Immunol 16, 1643-1656 (2004)
40. Feuerer, M., Hill, J. A., Mathis, D. & Benoist, C. Foxp31 regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol 10, 689-695 (2009)
41. Sakaguchi, S. Naturally arising CD41 regulatory t cells for immunologic selftolerance and negative control of immune responses. Annu Rev Immunol 22, 531-562 (2004) (Pubitemid 38680433)
42. Sakaguchi, S. et al. Foxp31CD251CD41natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212, 8-27 (2006) (Pubitemid 44116697)